Household cost of treating pregnancy-related complications in an urban setting: a study at the Korle Bu teaching hospital, Ghana Authors: Raphael Kwasi Gborgbortsi, Kofi Aduo-Adjei, Desmond Dzidzornu Otoo, Caesar Kaba Kogoziga, Serwaa Akoto Bawua, Richmond Owusu Published: 2026 ABSTRACT BackgroundThousands of women die annually from preventable pregnancy-related complications. The high cost of treating complications in pregnancy remains a significant setback to improving maternal health and averting maternal mortality. Efforts by the government of Ghana to improve access to skilled maternal health care led to the provision of free maternal health care under the National Health Insurance Scheme in 2012. However, household costs associated with pregnancy-related conditions is not well researched in Ghana. Therefore, this paper estimated the cost of treating pregnancy-related complications in Ghanaian households.MethodsA descriptive cross-sectional design was employed to estimate the household cost of treating pregnancy complications (PRCs) at the Korle Bu Teaching Hospital (KBTH). A systematic sampling technique was adopted to sample 102 pregnant women who received treatment for pregnancy-related complications between March and November 2022. A structured questionnaire was used to collect data from respondents. Data analysis was done using Microsoft Excel version 16 and STATA, 16. Sensitivity analysis was conducted by varying the cost of drugs at 9% and productivity loss due to absenteeism at the daily minimum wage.ResultsThe average cost of treating PRC was estimated at GHS 2,003.95 (US$265.07). The direct cost of treating PRCs accounts for 77.7%, while the indirect cost accounts for 22.2% of the total economic cost. The main drivers of the direct and indirect costs were the cost of feeding GHS 106,159.00 ($14,042.20) (41.7%) and productivity loss due to absenteeism at GHS57,906.34 ($7,659.57) (22.2%), respectively.ConclusionThe household cost of treating PRCs at the KBTH was very high, and policies and programs are required to support families to ease the economic burden on them. Background Maternal mortality (MM) is a major public health concern. The World Health Organization (WHO defined maternal mortality as “deaths occurring in women, while pregnant or within 42 days of termination of pregnancy irrespective of the duration and site of the pregnancy from any cause related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes” [1]. Pregnancy-related complications continue to pose a major threat to maternal health, but beyond the clinical consequences, they also impose substantial financial burdens on households. An estimated 810 women die from preventable pregnancy-related complications every day globally [2]. Women living in developing countries are 300 times more likely to die as a result of childbirth or pregnancy-related complications than those in developed countries [3]. The WHO also recommends that all pregnant women should have antenatal care (ANC) with a skilled provider, utilize the service of a skilled birth attendant (SBA) at birth, and obtain first postnatal care (PNC) within the first 24 h after birth as part of the measures to reduce MMR [4, 5]. Over the years, Ghana has made progress by reducing its maternal mortality rate (MMR) from 740 to 319/100,000 live births between 1990 and 2015 (Adu et al., 2021). Even though there is recent evidence of a reduction in maternal mortality worldwide, most developing countries like Ghana still lag in achieving Sustainable Development Goal (SDG) target 3.1, which seeks to reduce maternal mortality to 70 per 100,000 live births by 2030 [6, 7]. Reducing MM remains a priority for the government of Ghana and it’s donor agencies [8]. The Ghana government implemented policies which include free maternal health care policy in 2008 through the National Health Insurance Scheme to reduce the financial burden on pregnant women and their families and improve access to skilled and comprehensive maternal health care [9–11]. Although Ghana has implemented the free maternal health care policy under the NHIS, to reduce financial barriers to skilled maternal care, significant gaps remain. While the policy covers selected direct medical services such as antenatal care, routine laboratory tests, and treatment for delivery-related complications, households still incur considerable out-of-pocket payments. These payments include admission fees, diagnostics and drugs not covered under the scheme, and all direct non-medical costs such as transportation, feeding, and accommodation for caregivers. The indirect, direct non-medical costs and hidden costs such as feeding and transportation cost of treating PRC constitute a higher proportion of household income. This possess a huge financial burden preventing pregnant women from accessing CMC [9]. Despite these, there is limited evidence in on the full economic burden of treating pregnancy-related complications on households in Ghana. This paper sought to estimate the household cost of treating pregnancy-related complications in Ghanaian households. This paper aims to help policymakers to understand the economic burden of PRC on households and develop strategies to improve access to CMC. Materials and methods Study site This study was conducted at the maternity unit of the Korle Bu Teaching Hospital (KBTH). It is the largest teaching hospital in Ghana and was established in 1923. It receives obstetric cases from primary, secondary, and tertiary facilities across the country. The Hospital is in the Ablekuma South Constituency, Greater Accra the capital city of Ghana. The study site was selected because it presents an opportunity for a fair representation of the study population. It has a total bed capacity of about 2000 with 19 clinical departments. About 1500 patients are seen in the outpatient department (OPD), and 250 are admitted daily. However, the study was conducted among inpatients in the obstetrics and gynecology department, with average daily attendance and bed capacity of 64 and 260, respectively [12]. The number of maternal complications recorded in April 2022 at the Korle Bu Teaching Hospital included: hemorrhage (26), pre-eclampsia (37), eclampsia (21), infections (48), anemia (32), and unsafe abortion (18). Study design A descriptive cross-sectional quantitative study design was employed to estimate the direct, indirect, and intangible costs. Data was collected from December 2022 to January 2023 from the patient perspective. Data was obtained from pregnant women who were diagnosed of pregnancy-related complications including placental previa, placenta abruption, pre-eclampsia/eclampsia and anaemia between March and November 2022 at the KBTH. Sample size determination A standard formula 𝑛 = \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\left[\frac{{\mathrm{Z}}_{\mathrm{a}/2}\mathrm{\sigma\:}}{\mathit{E}}\right]}^{2}$$\end{document}for continuous outcome variable sample size determination described by Johnston et al., (2016), was used in this study. Data from a study in a similar setting where household cost of treating cancer was estimated was used in the calculation. The findings revealed that average monthly household expenditure was estimated at GHS 231.00 with a standard deviation of GHS 127.50 (Gyau, 2016). We acknowledge that the use of cost data from a different medical condition may not perfectly reflect the pregnancy-related complications but provides acceptable estimates. By substituting these figures into the formular (where: n = sample size; \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\mathrm Z}_{\mathrm a/2}$$\end{document} is the critical value (1.96) of 95% confidence level; σ is the Standard deviation: GHS127.5\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathit\:\mathit;\mathit\:E$$\end{document} is the margin of error estimated at GHS26.00) and accounting for a 10% non-response rate, a sample size of 102 was estimated. Thus, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\mathrm{n}={\left(\frac{1.96\:\times\:127.5}{26}\right)}^{2}$$\end{document} = 92.4; Non-response = 92.4*0.1 = 9.2 Hence sample size = 92.4 + 9.2 = 101.6; approximately 102 Sampling procedure A systematic sampling technique was used to select eligible participants. A total of 4,943 pregnant women who visited the Obstetrics and Gynaecology (O&G) department with complications between March and November 2022 were extracted from the attendance register of the hospital’s electronic medical records system (Light-wave Health Information System - LHIMS). This number was subjected to the inclusion and exclusion criteria. Pregnant women who were admitted and underwent treatment and recovered from any of the four PRCs (i.e., Pre-eclampsia/eclampsia, anaemia, placenta previa, and placental abruption) within the past nine months prior to the data collection were included in the study. However, those who were still on admission at the time of data collection and/or failed to give their consent to participate in the study were excluded. After applying the inclusion and the exclusion criteria, only 1,472 out of 4,943 pregnant women remained in the dataset. Upon further assessment for eligibility, only 417 pregnant women who met the inclusion criteria were recruited for the study. The total number of eligible participants (417) was divided by the sample size (102) to obtain a sampling interval of approximately 4. The first participant was randomly selected between the 1st and 4th participant of the list. The 3rd participant was selected as a result. The remaining participants were selected using the sampling interval (4) until the 102nd participant was selected. This approach was chosen to reduce bias in the selection of participants. Finally, 102 participants were randomly selected and interviewed. The flow chart indicating a summary of the sampling procedure is illustrated in Fig. 1 below. Fig. 1Flow chart showing sampling procedure Flow chart showing sampling procedure Data collection Data collection was done using two approaches. Data was extracted from medical records and a structured questionnaire was used for data collection using face to face interviews. A medical records assistant extracted patient information from the hospital’s electronic medical records system. Two midwives administered the questionnaire after 5 days of training on the data collection tool. A face-to-face interview was conducted using questionnaires to obtain relevant information from participants who consented to participate in the study. Data processing and analysis Microsoft Excel version 16 was used for data entry, cleaning, and analysis. Descriptive statistics on socio-demographic characteristics of the study respondents were done and presented as frequencies and percentages. The direct cost was estimated by adding all medical and non-medical expenditure made while receiving treatment for PRCs. The direct medical cost (DMC) comprised of cost of registration, admission, drugs, laboratory investigations, and radiological imaging studies (scan). Although the NHIS provides free registration and exemption from premium payments and covers routine laboratory tests, selected essential medicines, antenatal care, normal delivery, emergency Caesarean section, and treatment for pregnancy-related complications, it has become common practice for mothers to make some form of out-of-pocket payments. The cost analysis included only out-of-pocket expenditures borne by households. Services covered under the NHIS were excluded from household cost computations since they did not impose direct financial payments on the respondents. Non-medical costs such as traveling expenses, cost of accommodation, and feeding (food and drinks) were also calculated. To determine the indirect cost, the human capital approach was used to measure productivity losses (PL) by participants and their caregivers due to absenteeism from work and time travel to and from the KBTH. For respondents who were employed and had a monthly income, their current net monthly income was used to estimate their PL due to absenteeism. This estimation was done by dividing their income by 22 days to determine the daily wage. The 22 days is the average number of working days of the month in Ghana. The daily wage was then multiplied by the number of days they were absent from work due to the PRC. However, for respondents without an income, their PL was estimated using the prevailing national daily minimum wage of 12.57 Ghana cedis. This amount was used to multiply the number of days spent on admission to estimate the overall PL. The hourly rates for the two categories of respondents were estimated by dividing the daily wage by 8 h. An hourly rate of 8 was used because the average working hours as determined by the fair wages and salaries commission. The hourly rates were used to multiply the number of hours spent traveling to and from the KBTH to estimate PL due to travel time. The economic cost was estimated as the sum of direct and the indirect cost (PL). All the estimated cost were calculated in Ghana cedis and converted into United States Dollars (US$). The prevailing Bank of Ghana exchange rate for 2022, thus US$1 = GHS7.56 was used [13]. Sensitivity analysis (SA) was calculated by varying cost of drugs and PL due to absenteeism. The cost of drugs was varied at 9%, while PL due to absenteeism was varied using the daily minimum wage (DMW) of GHS12.57 for all respondents. Ethics approval and consent to participate This study which was conducted in accordance with the ethical principles of the Declaration of Helsinki received ethical clearance from the Institutional Review Board (KBTH-RIB000233/2022) of the Korle Bu Teaching Hospitals prior to commencement. Permission was obtained from the medical directorate and the obstetrics and gynecology department of the Korle Bu Teaching Hospital to collect data from pregnant women. Written informed consent was obtained from all study participants. Results Socio-demographic characteristics The results indicate that half 51(50.0%) of the respondents are within the age group 31 and 40 years, while 6(5.9%) were below 21 years, representing the youngest age group. Most, 82(80.4%), were married, and the rest, 20(19.6%), were single. The predominant occupation was trading 38 (37.3%), whiles being a housewife 4(3.9%) was the least. It is worth noting that 13(12.7%) were unemployed. Most of the respondents 62(60.8%) had conceived at least 3 times and 76(74.5%) had given birth less than 3 times. Even though 97(95.1%) had national health insurance, only 3(2.9%) had private or cooperate health insurance. Most respondents spent less than eight days on admission 39(38.2%), while only 11(10.8%) spent between 15 and 21 days on admission (Table 1). Table 1Socio-demographic characteristicsVariablesFrequency (N = 102)Pregnancy (%)MeanAge groups (years) < 2165.931.1 21–303837.3 31–405150.0 41 +76.9Marital status Married8280.4 Single2019.6Occupation Nurse76.9 Trader3837.3 Artisan1413.7 Cook76.9 Housewife43.9 Student54.9 Others1413.7 Unemployed1312.7Gravidity < 34039.23.3 3 +6260.8Parity < 37674.51.5 3 +2625.5Household monthly income No income109.8841.9 < 30198.8 301–6002827.5 601–9002524.5 901–120098.8 1201–150076.9 1501 +1413.7Insurance status (NHIS) No54.9 Yes9795.1Insurance status (Private) No9997.1 Yes32.9Duration of admission (Days) < 83938.215 8–143534.3 15–211110.8 22 +1716.7 Table 1Socio-demographic characteristicsVariablesFrequency (N = 102)Pregnancy (%)MeanAge groups (years) < 2165.931.1 21–303837.3 31–405150.0 41 +76.9Marital status Married8280.4 Single2019.6Occupation Nurse76.9 Trader3837.3 Artisan1413.7 Cook76.9 Housewife43.9 Student54.9 Others1413.7 Unemployed1312.7Gravidity < 34039.23.3 3 +6260.8Parity < 37674.51.5 3 +2625.5Household monthly income No income109.8841.9 < 30198.8 301–6002827.5 601–9002524.5 901–120098.8 1201–150076.9 1501 +1413.7Insurance status (NHIS) No54.9 Yes9795.1Insurance status (Private) No9997.1 Yes32.9Duration of admission (Days) < 83938.215 8–143534.3 15–211110.8 22 +1716.7 Socio-demographic characteristics Distribution of pregnancy-related complications (PRCs) Out of the 4 PRCs that were assessed, pre-eclampsia/eclampsia 55(53.9%) was the highest PRC, followed by anaemia 32(31.4%), placental abruption 9(8.8%) and placenta previa 6(5.9%) (Fig. 2). Fig. 2Distribution of pregnancy-related complications (PRCs) Distribution of pregnancy-related complications (PRCs) Distribution of direct cost of PRCs The total economic cost of treating PRCs is GHS204,403.35 (US$27,037.48), with an average cost of GHS2,003.95 (US$265.07). The minimum cost of treating a PRC is GHS324.00 (US$42.86) and a maximum of GHS9,597.57 (US$1,269.52). Pre-eclampsia/eclampsia (55.9%) had the highest proportion of the total cost, and placenta abruption 9.3% had the least cost which constitute GHS114,373.41 (US$15,128.76) and GHS18,997.35 (US$2,512.88) respectively. The average cost of treating anaemia, pre-eclampsia/eclampsia, placenta previa, and placental abruption is +/- SD GHS1,416.74 (US$187.40), +/- SD GHS2,079.52 (US$275.07), +/- SD GHS4,282.84 (US$566.51) and +/- SD GHS2,110.82 (US$279.21) respectively (Table 2). Table 2Distribution of direct cost of treating PRCCost itemCost per PRCGHS(US$)MinGHS(US$)MaxGHS(US$)AverageGHS(US$)Percentage (%)Anaemia45,335.58 (5,996.77)324.00 (42.86)8,343.90 (1,103.69)1,416.74 (187.40)22.2Pre-eclampsia/Eclampsia114,373.41 (15,128.76)473.00 (62.57)9,597.57 (1,269.52)2,079.52 (275.07)55.9Placenta previa25,697.01 (3,399.08)1,339.44 (177.17)7,914.13 (1,046.84)4,282.84 (566.51)12.6Placental abruption18,997.35 (2,512.88)992.80 (131.32)3,364.04 (444.98)2,110.82 (279.21)9.3Grand Total204,403.35 (27,037.48)324.00 (42.86)9,597.57 (1,269.52)2,003.95 (265.07)100.0 Table 2Distribution of direct cost of treating PRCCost itemCost per PRCGHS(US$)MinGHS(US$)MaxGHS(US$)AverageGHS(US$)Percentage (%)Anaemia45,335.58 (5,996.77)324.00 (42.86)8,343.90 (1,103.69)1,416.74 (187.40)22.2Pre-eclampsia/Eclampsia114,373.41 (15,128.76)473.00 (62.57)9,597.57 (1,269.52)2,079.52 (275.07)55.9Placenta previa25,697.01 (3,399.08)1,339.44 (177.17)7,914.13 (1,046.84)4,282.84 (566.51)12.6Placental abruption18,997.35 (2,512.88)992.80 (131.32)3,364.04 (444.98)2,110.82 (279.21)9.3Grand Total204,403.35 (27,037.48)324.00 (42.86)9,597.57 (1,269.52)2,003.95 (265.07)100.0 Distribution of direct cost of treating PRC Direct cost of treating PRCs The total direct cost of treating PRCs is GHS204,405.70 (US$27,037.79). The direct non-medical cost is GHS128,030.00 (US$16,935.19) (62.6%), accounting for the highest proportion, while the direct medical cost is GHS76,375.70 (US$10,102.61) (37.4%). Admission fee GHS39,041.70 (US$5,164.25) (19.10%) is the primary driver of the direct medical cost, and the cost of feeding GHS106,159.00 (US$14,042.20) (51.9%) constitutes the larger proportion of the direct non-medical cost. However, the cost of feeding accounted for more than half (51.9%) GHS106,159.00 (US$14,042.20) of the direct cost of treating PRCs. The average direct medical cost of treating PRCs is estimated at +/- SD GHS748.75 (US$99.04), while the average direct non-medical cost was estimated at GHS1,225.20 (US$162.06) (Table 3). Table 3Direct cost of treating PRCsCost itemCostGHS (US$)Average costGHS (US$)Percentage(%)Direct medical cost Registration1,905.00 (251.98)18.68 (2.47)0.9 Admission fee39,041.70 (5,164.25)382.76 (50.63)19.1 Lab/scan10,780.00 (1,425.93)52.85 (6.99)5.3 Drugs24,649.00 (3,260.45)241.66 (31.97)12.1 Subtotal76,375.70 (10,102.61)748.75 (99.04)37.4Direct non-medical cost Cost of transportation7,321.00 (968.39)51.45 (6.81)3.6 Cost of feeding106,159.00 (14,042.20)520.39 (68.83)51.9 Accommodation14,550.00 (1,924.60)142.65 (18.87)7.1 Subtotal128,030.00 (16,935.19)1,225.20 (162.06)62.6 Grand total204,405.70 (27,037.79)2,003.95 (265.07)100.0 Table 3Direct cost of treating PRCsCost itemCostGHS (US$)Average costGHS (US$)Percentage(%)Direct medical cost Registration1,905.00 (251.98)18.68 (2.47)0.9 Admission fee39,041.70 (5,164.25)382.76 (50.63)19.1 Lab/scan10,780.00 (1,425.93)52.85 (6.99)5.3 Drugs24,649.00 (3,260.45)241.66 (31.97)12.1 Subtotal76,375.70 (10,102.61)748.75 (99.04)37.4Direct non-medical cost Cost of transportation7,321.00 (968.39)51.45 (6.81)3.6 Cost of feeding106,159.00 (14,042.20)520.39 (68.83)51.9 Accommodation14,550.00 (1,924.60)142.65 (18.87)7.1 Subtotal128,030.00 (16,935.19)1,225.20 (162.06)62.6 Grand total204,405.70 (27,037.79)2,003.95 (265.07)100.0 Direct cost of treating PRCs Indirect cost of treating PRCs Table 4 indicates that the indirect cost of treating PRCs is GHS58,340.22 (US$ 7,716.96). A more significant proportion of the indirect cost is attributable to productivity losses due to absenteeism 99.3% (GHS57,906.34 (US$7,659.57)) while productivity losses due to travel time to the health facility accounted for 0.7% (GHS369.45 (US$48.87)). The average indirect cost of treating PRCs was estimated at GHS517.96 (US$75.66). However, average productivity loss due to absenteeism and travel time was estimated at +/- SD GHS567.71 (US$75.09) and +/- SD GHS4.25 (US$0.56), respectively (Table 4). Table 4Indirect cost of treating PRCsCost itemCostGHS (US$)Average costGHS (US$)Percentage(%)Productivity loss due to absenteeism57,906.34 (7,659.57)567.71 (75.09)99.3Productivity loss due to travel time433.88 (57.39)4.25 (0.56)0.7Total58,340.22 (7,716.96)571.96 (75.66)100.00 Table 4Indirect cost of treating PRCsCost itemCostGHS (US$)Average costGHS (US$)Percentage(%)Productivity loss due to absenteeism57,906.34 (7,659.57)567.71 (75.09)99.3Productivity loss due to travel time433.88 (57.39)4.25 (0.56)0.7Total58,340.22 (7,716.96)571.96 (75.66)100.00 Indirect cost of treating PRCs Economic cost of treating PRCs Figure 3 represents the economic cost of treating PRCs. The indirect cost of treating PRCs accounts for 22.2%, while the direct cost accounts for 77.8% of the total cost (Fig. 3). Fig. 3Cost of treating PRCs by type of cost Cost of treating PRCs by type of cost Economic cost of treating PRCs The economic cost of treating PRCs was estimated at GHS262,745.92 (US$34,754.75). The direct cost constituted 77.8% estimated at GHS204,405.70 (US$27,037.79) being the most significant proportion of the total cost, whiles indirect cost accounted for 22.2% estimated at GHS50,499.30 (US$6,679.8). The main driver of the economic cost was the cost of feeding GHS106,159.00 (US$14,042.20) constituting 40.4% of the total cost. The cost of feeding was estimated at GHS106,159.00 (US$14,042.20). Similarly, productivity loss due to absenteeism GHS57,906.34 (US$7,659.57) representing 22.2% was the highest cost item of the indirect cost (Table 5). Table 5Economic cost of treating PRCsCost itemCost GHS (US$)Percentage (%)Direct Cost Registration1,905.00 (251.98)0.7 Admission fee39,041.70 (5,164.25)14.9 Lab/scan10,780.00 (1,425.93)4.1 Drugs24,649.00 (3,260.45)9.4 Cost of transportation7,321.00 (968.39)2.8 Cost of feeding106,159.00 (14,042.20)40.4 Accommodation14,550.00 (1,924.60)5.5 Sub-total204,405.70 (27,037.79)77.8Indirect cost Productivity loss due to absenteeism57,906.34 (7,659.57)22.0 Productivity loss due to travel time433.88 (57.39)0.2 Sub-total58,340.22 (7,716.96)22.2 Grand total262,745.92 (34,754.75)100.00 Table 5Economic cost of treating PRCsCost itemCost GHS (US$)Percentage (%)Direct Cost Registration1,905.00 (251.98)0.7 Admission fee39,041.70 (5,164.25)14.9 Lab/scan10,780.00 (1,425.93)4.1 Drugs24,649.00 (3,260.45)9.4 Cost of transportation7,321.00 (968.39)2.8 Cost of feeding106,159.00 (14,042.20)40.4 Accommodation14,550.00 (1,924.60)5.5 Sub-total204,405.70 (27,037.79)77.8Indirect cost Productivity loss due to absenteeism57,906.34 (7,659.57)22.0 Productivity loss due to travel time433.88 (57.39)0.2 Sub-total58,340.22 (7,716.96)22.2 Grand total262,745.92 (34,754.75)100.00 Economic cost of treating PRCs Duration of admission by number of cases and total economic cost Figure 4 shows the duration of admission compared to the number of cases and the associated economic cost. The result shows that most of the respondents (38.2%) spend less than eight days on admission. In comparison, a smaller proportion of patients (16.7%) who spent at least 22 days incurred the highest proportion (43.2%) of the total economic cost (Fig. 4). Fig. 4Duration of admission by number of cases and total economic cost Duration of admission by number of cases and total economic cost Sensitivity analysis Table 6 shows the results of the one-way sensitivity analysis (SA) which was conducted by varying the cost of drugs by a 9% increase and varying the productivity loss due to absenteeism by daily minimum wage (DMW) (GHS12.57). Varying the cost of drugs yielded a 0.2% change in the total direct and indirect costs, respectively. However, varying the productivity loss due to absenteeism produces a 10.9% change in total direct and indirect costs. Furthermore, a multi- way sensitivity analysis was done by varying the cost of drugs and productivity loss by 9% and DMW (GHS12.57). The multi-way sensitivity analysis resulted in an 11.0% increase in total direct and indirect costs, respectively (Table 6). Table 6Sensitivity analysisType of costInitialpercentage (%)Varying costof drugs at 9% (A)Varyingproductivity loss due to absenteeism by daily minimum wage(GHS12.57) (B)Varying both A and B at 9%Direct cost80.280.491.191.2Percentage change in total direct cost0.210.911.0Indirect cost19.819.68.98.8Percentage change in total indirect cost0.210.911.0 Table 6Sensitivity analysisType of costInitialpercentage (%)Varying costof drugs at 9% (A)Varyingproductivity loss due to absenteeism by daily minimum wage(GHS12.57) (B)Varying both A and B at 9%Direct cost80.280.491.191.2Percentage change in total direct cost0.210.911.0Indirect cost19.819.68.98.8Percentage change in total indirect cost0.210.911.0 Sensitivity analysis Discussion This study focuses on estimating the household cost of treating PRCs in an urban setting. The total direct cost of treating PRCs was GHS204,405.70 (US$27,037.79). This cost accounts for 80.2% of the total economic cost of treating PRCs. The total direct medical cost of GHS76,375.70 (US$10,102.61) (37.4%) forms the least proportion of the direct cost. This result is in contrast with a similar study conducted in Ethiopia among pregnant women to estimate the cost of treating maternal complications, and associated factors revealed that the total cost of treatment for direct medical cost for drug and diagnostic tests constitutes the major share out of total health expenditure [14]. However, this study found that the cost of admission (51.1%) and drugs (32.3%) were the major components of the direct medical cost. Another cross- sectional study conducted in a rural setting of Ghana at the primary level facility to estimate the households cost of treating maternal complications posit that the direct medical costs incurred constitute the more significant proportion (70%) of the direct cost [6]. This result is inconsistent with our findings which show that the direct non-medical cost of GHS128,030.00 (US$16,935.19) (62.6%) of treating PRCs constitutes the larger share of the total direct cost. The differences between these previous studies in Ghana and Ethiopia may be attributed to the types of PRC that were studied in each of these studies. The average cost of treating pre-eclampsia/eclampsia at the KBTH was estimated at GHS2,079.52 (US$275.07). This result is inconsistent with a cross-sectional study conducted by Fox et al. [15] which estimated the cost of treating pre-eclampsia to be €455 (equivalent to US$577.75 at 1.05; 2022 mid-year exchange rate). This difference may be attributed to contextual economic factors. The study also estimated the average feeding cost for the patient and their caregivers at GHS520.39 (US$68.83). Comparing this amount to the findings from a similar study conducted by Dalaba et al. [6] to estimate the household cost of treating maternal complications revealed that the median expenditure made on food for both patient and caretaker was estimated at US$9.47 per person. The vast differences in the cost could be due to the settings where the studies were conducted and the different economic situations under which both studies were conducted. Also, the average cost of transportation incurred by patients and their caregivers was estimated at GHS51.45 (US$6.81). The cost of transportation represents 2.9% of the total economic cost. This result is inconsistent with a similar study conducted in a rural community in Ghana, where the median transportation cost was estimated at US$13.48 per person, including the patient and their caregivers representing 32% of the total cost [6]. This difference may be attributed to proximity of households and ease of access to health facilities for receiving maternal care. The indirect cost was estimated by calculating the productivity losses due to absenteeism from work and travel time for the patient and their caregivers. The indirect cost of treating PRCs is estimated at GHS57,906.34, which constitutes 22.2% of the total economic cost of treating PRCs. This result is in contrast with a similar study carried out by Dalaba et al. [6] among pregnant women to estimate the household cost of treating maternal complications which found that indirect costs (79%) accounted for the most significant proportion of the total cost. This study also indicated that a larger proportion of the indirect cost is attributable to productivity loss due to absenteeism GHS57,906.34 (99.3%). In comparison, productivity loss due to travel time to the health facility accounted for GHS433.88 (0.7%). The average indirect cost of treating PRCs is estimated at GHS571.96 (US$75.66). However, average productivity loss due to absenteeism and travel time was estimated at GHS567.71 (US$75.09) and GHS4.25 (US$0.56), respectively. These results are inconsistent with the findings from a similar study conducted by Dalaba et al. [6] in a rural community in Ghana which revealed that the median indirect cost attributed to productivity losses was estimated at US$5.2 per person. Limitations The study acknowledges the limitation of a possible recall bias since participants were required to recall events such as time spent traveling from KBTH in the past months. Also, there was no evidence of payments made for direct non-medical costs to verify information provided by the study participants. This information is likely to result in irregular estimation costs associated with non-medical expenses leading to either under or over-estimation. The relatively small sample size was determined using a standard formula appropriate for continuous cost outcomes and was adequate for estimating mean household costs. However, the findings may have limited generalizability beyond similar urban tertiary-care settings. Conclusion The study concludes that at the direct cost incurred by pregnant women for treating PRCs in Ghana was high with t direct cost being the most significant cost component. Consequently, cost of feeding was found to be the main driver of the direct cost. Even though the indirect cost incurred by pregnant women was less than one-third of the total cost, productivity loss due to absenteeism while on admission to seek treatment accounted for almost the entire indirect cost. Also, most of the pregnant women reported moderate to high intangible burdens as a result of PRCs. They indicated varied psychological problems, including pain, stress, and fear of the complication's outcome, unhappiness, and disruption of social life. Generally, the household cost of treating PRCs at the KBTH is a significant challenge confronting pregnant women and their households. Generally, pregnant women should be encouraged to initiate early antenatal to be able to prevent or detect possible complications and seek early intervention. By so doing it will reduce hospitalization and consequently reduce overspending on treatment on PRCs. It was also observed that, the institution operates a composite billing system where pregnant women were charged a fixed amount for admission regardless of whether they use specific services or not. This will help to reduce the financial burden; an itemized billing system should be introduced at the maternity department to ensure that pregnant women pay for only services they receive.Future research should target comparing the cost of treating PRCs at all levels of health care systems in Ghana. Finally, a future should aim at estimating the cost of treating the top five major courses of maternal morbidity and mortality.